🇺🇸 FDA
Patent

US 11672785

Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs

granted A61KA61K31/437A61K31/4545

Quick answer

US patent 11672785 (Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs) held by Olema Pharmaceuticals, Inc. expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Olema Pharmaceuticals, Inc.
Grant date
Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/437, A61K31/4545, A61K31/475, A61K31/506